Systematic Light Exposure for Fatigue in Breast Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

January 25, 2018

Primary Completion Date

January 26, 2022

Study Completion Date

January 26, 2022

Conditions
Cancer-related Problem/ConditionFatigueCircadian Rhythm Disorders
Interventions
DEVICE

Light Glasses (Experimental)

The light glasses emit light from LEDs at a distance of 15 millimeters (15mm, 0.015.) from the eye. The device Is classified as safe for the eyes in accordance with the international standard IEC 62471 and complies with the United States of America's FCC marking, and is designed to be worn on the participant's head, similarly to a pair of glasses. For safety purposes, the light glasses do not contain UV or infra-red light.

DEVICE

Light Glasses (Comparison)

The light glasses emit light from LEDs at a distance of 15 millimeters (15mm, 0.015.) from the eye. The device Is classified as safe for the eyes in accordance with the international standard IEC 62471 and complies with the United States of America's FCC marking, and is designed to be worn on the participant's head, similarly to a pair of glasses. For safety purposes, the light glasses do not contain UV or infra-red light.

Trial Locations (3)

10029

Icahn School of Medicine at Mount Sinai, New York

10065

Memorial Sloan-Kettering Cancer Center, New York

91010

City of Hope Cancer Center, Duarte

All Listed Sponsors
collaborator

Memorial Sloan Kettering Cancer Center

OTHER

collaborator

National Cancer Institute (NCI)

NIH

collaborator

City of Hope Medical Center

OTHER

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT03217201 - Systematic Light Exposure for Fatigue in Breast Cancer Patients | Biotech Hunter | Biotech Hunter